govt.fyi
Back to S8772-2025
NY State Legislature· S8772-2025Signed by Governor

Relates to high deductible health plans and health savings accounts; relates to the effectiveness of a chapter of the laws of 2025, the official text

Shown verbatim: the complete text as captured from the official source posted by the New York State Senate, fetched 2026-08-11. Nothing is edited or removed. Where this bill amends existing law, language marked for deletion in the official source appears here in brackets. The official bill page.
S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8772
 
                             I N  S E N A T E
 
                              January 8, 2026
                                ___________
 
 Introduced  by  Sen.  BAILEY -- read twice and ordered printed, and when
   printed to be committed to the Committee on Rules
 
 AN ACT to amend the insurance law, in relation to high deductible health
   plans and health savings accounts; and to amend a chapter of the  laws
   of  2025 amending the insurance law relating to high deductible health
   plans and health savings accounts, as proposed  in  legislative  bills
   numbers  S.  6895-A  and  A.  5367-A, in relation to the effectiveness
   thereof
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Subsection  (n)  of section 3216 of the insurance law, as
 added by a chapter of the laws of 2025 amending the insurance law relat-
 ing to high deductible health plans  and  health  savings  accounts,  as
 proposed  in  legislative  bills  numbers  S.  6895-A  and A. 5367-A, is
 amended to read as follows:
   (n) With respect to high deductible health plans offered  in  conjunc-
 tion  with a [health reimbursement account or a] health savings account,
 if application of any cost sharing requirements would result  in  health
 savings  account ineligibility under section two hundred twenty-three of
 the internal revenue code, such [cost sharing  requirement  shall  apply
 for  health  savings account-qualified high deductible health plans with
 respect to the deductible of such a plan, only after  the  enrollee  has
 satisfied  the minimum deductible under section two hundred twenty-three
 of the internal revenue code, except with respect to items  or  services
 that  are  considered  preventive  care  pursuant to subparagraph (C) of
 paragraph two of subsection c of section two hundred twenty-three of the
 internal revenue code, in which case the  cost-sharing  requirements  of
 this  section  shall  apply regardless of whether the minimum deductible
 required under section two hundred twenty-three of the internal  revenue
 code  has  been  satisfied] COVERAGE MAY BE SUBJECT TO THE PLAN'S ANNUAL
 DEDUCTIBLE.
   § 2. Subparagraph (B) of paragraph 11 of  subsection  (i)  of  section
 3216  of  the  insurance  law,  as amended by chapter 424 of the laws of
 2024, is amended to read as follows:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD07833-06-6
 S. 8772                             2
 
   (B) Such coverage required pursuant to subparagraph (A) or (C) of this
 paragraph shall not be subject to annual deductibles or coinsurance.  If
 under  federal  law,  application  of  this  requirement would result in
 health savings account ineligibility under 26 USC 223, this  requirement
 shall  apply for health savings account-qualified high deductible health
 plans with respect to the deductible of such a plan after  the  enrollee
 has  satisfied  the [minimum] PLAN deductible [under 26 USC 223], except
 for with respect to items or services that are preventive care  pursuant
 to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph
 shall  apply  regardless of whether the [minimum] PLAN deductible [under
 26 USC 223] has been satisfied.
   § 3. Paragraph 37 of subsection (i) of section 3216 of  the  insurance
 law,  as  amended by chapter 117 of the laws of 2023, is amended to read
 as follows:
   (37) Any policy that provides coverage for  prescription  drugs  shall
 apply  any third-party payments, financial assistance, discount, voucher
 or other price reduction instrument for out-of-pocket expenses  made  on
 behalf  of  an insured individual for the cost of a prescription drug to
 the insured's deductible, copayment, coinsurance, out-of-pocket maximum,
 or any other cost-sharing  requirement  when  calculating  such  insured
 individual's  overall  contribution  to any out-of-pocket maximum or any
 cost-sharing requirement. If under  federal  law,  application  of  this
 requirement  would  result in health savings account ineligibility under
 26 USC 223, this requirement shall apply for health savings account-qua-
 lified high deductible health plans with respect to  the  deductible  of
 such  a plan after the enrollee has satisfied the [minimum] PLAN deduct-
 ible [under 26 USC 223], except for with respect to  items  or  services
 that  are preventive care pursuant to 26 USC 223(c)(2)(C), in which case
 the requirements of this paragraph shall apply regardless of whether the
 [minimum] PLAN deductible [under 26 USC 223] has  been  satisfied.  This
 paragraph  only  applies  to  a  prescription  drug that is either (A) a
 brand-name drug without an AB rated generic equivalent, as determined by
 the United States Food and Drug Administration; or (B) a brand-name drug
 with an AB rated generic equivalent, as determined by the United  States
 Food  and  Drug Administration, and the insured has access to the brand-
 name drug through prior authorization by  the  insurer  or  through  the
 insurer's  appeal  process, including any step-therapy process; or (C) a
 generic drug the insurer will cover, with or without prior authorization
 or an appeal process.
   § 4. Subsection (v) of section 3221 of the insurance law, as added  by
 a  chapter  of  the  laws of 2025 amending the insurance law relating to
 high deductible health plans and health savings accounts, as proposed in
 legislative bills numbers S. 6895-A and A. 5367-A, is amended to read as
 follows:
   (v) With respect to high deductible health plans offered  in  conjunc-
 tion  with a [health reimbursement account or a] health savings account,
 if application of any cost sharing requirements would result  in  health
 savings  account ineligibility under section two hundred twenty-three of
 the internal revenue code, such [cost sharing  requirement  shall  apply
 for  health  savings account-qualified high deductible health plans with
 respect to the deductible of such a plan, only after  the  enrollee  has
 satisfied  the minimum deductible under section two hundred twenty-three
 of the internal revenue code, except with respect to items  or  services
 that  are  considered  preventive  care  pursuant to subparagraph (C) of
 paragraph two of subsection c of section two hundred twenty-three of the
 internal revenue code, in which case the  cost-sharing  requirements  of
 S. 8772                             3

 this  section  shall  apply regardless of whether the minimum deductible
 required under section two hundred twenty-three of the internal  revenue
 code  has  been  satisfied] COVERAGE MAY BE SUBJECT TO THE PLAN'S ANNUAL
 DEDUCTIBLE.
   §  5.  Subparagraph  (B)  of paragraph 11 of subsection (l) of section
 3221 of the insurance law, as amended by chapter  424  of  the  laws  of
 2024, is amended to read as follows:
   (B) Such coverage required pursuant to subparagraph (A) or (C) of this
 paragraph  shall not be subject to annual deductibles or coinsurance. If
 under federal law, application  of  this  requirement  would  result  in
 health  savings account ineligibility under 26 USC 223, this requirement
 shall apply for health savings account-qualified high deductible  health
 plans  with  respect to the deductible of such a plan after the enrollee
 has satisfied the [minimum] PLAN deductible [under 26 USC  223],  except
 for  with respect to items or services that are preventive care pursuant
 to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph
 shall apply regardless of whether the [minimum] PLAN  deductible  [under
 26 USC 223] has been satisfied.
   §  6.  Paragraph 21 of subsection (l) of section 3221 of the insurance
 law, as amended by chapter 117 of the laws of 2023, is amended  to  read
 as follows:
   (21) Every group or blanket policy delivered or issued for delivery in
 this  state  that  provides coverage for a prescription drug shall apply
 any third-party payments, financial  assistance,  discount,  voucher  or
 other  price  reduction  instrument  for  out-of-pocket expenses made on
 behalf of an insured individual for the cost of  prescription  drugs  to
 the insured's deductible, copayment, coinsurance, out-of-pocket maximum,
 or  any  other  cost-sharing  requirement  when calculating such insured
 individual's overall contribution to any out-of-pocket  maximum  or  any
 cost-sharing  requirement.  If  under  federal  law, application of this
 requirement would result in health savings account  ineligibility  under
 26 USC 223, this requirement shall apply for health savings account-qua-
 lified  high  deductible  health plans with respect to the deductible of
 such a plan after the enrollee has satisfied the [minimum] PLAN  deduct-
 ible  [under  26  USC 223], except for with respect to items or services
 that are preventive care pursuant to 26 USC 223(c)(2)(C), in which  case
 the requirements of this paragraph shall apply regardless of whether the
 [minimum]  PLAN  deductible  [under 26 USC 223] has been satisfied. This
 paragraph only applies to a prescription  drug  that  is  either  (A)  a
 brand-name drug without an AB rated generic equivalent, as determined by
 the United States Food and Drug Administration; or (B) a brand-name drug
 with  an AB rated generic equivalent, as determined by the United States
 Food and Drug Administration, and the insured has access to  the  brand-
 name  drug  through  prior  authorization  by the insurer or through the
 insurer's appeal process, including any step-therapy process; or  (C)  a
 generic drug the insurer will cover, with or without prior authorization
 or an appeal process.
   § 7. Subsection (ww) of section 4303 of the insurance law, as added by
 a  chapter  of  the  laws of 2025 amending the insurance law relating to
 high deductible health plans and health savings accounts, as proposed in
 legislative bills numbers S. 6895-A and A. 5367-A, is amended to read as
 follows:
   [(ww)] (XX) With respect to high deductible health  plans  offered  in
 conjunction  with  a  [health reimbursement account or a] health savings
 account, if application of any cost sharing requirements would result in
 health savings account ineligibility under section two  hundred  twenty-
 S. 8772                             4
 
 three of the internal revenue code, such [cost sharing requirement shall
 apply  for health savings account-qualified high deductible health plans
 with respect to the deductible of such a plan, only after  the  enrollee
 has  satisfied  the minimum deductible under section two hundred twenty-
 three of the internal revenue code, except  with  respect  to  items  or
 services  that  are  considered preventive care pursuant to subparagraph
 (C) of paragraph two of subsection c of section two hundred twenty-three
 of the internal revenue code, in which case  the  cost-sharing  require-
 ments  of  this  section  shall  apply regardless of whether the minimum
 deductible required under section two hundred twenty-three of the inter-
 nal revenue code has been satisfied] COVERAGE  MAY  BE  SUBJECT  TO  THE
 PLAN'S ANNUAL DEDUCTIBLE.
   § 8. Subparagraph (F) of paragraph 1 of subsection (p) of section 4303
 of  the insurance law, as amended by chapter 424 of the laws of 2024, is
 amended to read as follows:
   (F) The coverage required in this paragraph or paragraph two  of  this
 subsection shall not be subject to annual deductibles or coinsurance. If
 under  federal  law,  application  of  this  requirement would result in
 health savings account ineligibility under 26 USC 223, this  requirement
 shall  apply for health savings account-qualified high deductible health
 plans with respect to the deductible of such a plan after  the  enrollee
 has  satisfied  the [minimum] PLAN deductible [under 26 USC 223], except
 for with respect to items or services that are preventive care  pursuant
 to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph
 shall  apply  regardless of whether the [minimum] PLAN deductible [under
 26 USC 223] has been satisfied.
   § 9. Subsection (tt) of section 4303 of the insurance law, as  amended
 by chapter 117 of the laws of 2023, is amended to read as follows:
   (tt) Every contract issued by a medical expense indemnity corporation,
 hospital   service  corporation,  or  health  service  corporation  that
 provides coverage for a prescription drug shall  apply  any  third-party
 payments,   financial  assistance,  discount,  voucher  or  other  price
 reduction instrument for out-of-pocket expenses made  on  behalf  of  an
 insured  individual  for the cost of prescription drugs to the insured's
 deductible, copayment, coinsurance, out-of-pocket maximum, or any  other
 cost-sharing  requirement  when  calculating  such  insured individual's
 overall contribution to any out-of-pocket maximum  or  any  cost-sharing
 requirement. If under federal law, application of this requirement would
 result  in  health  savings account ineligibility under 26 USC 223, this
 requirement shall apply for health savings account-qualified high deduc-
 tible health plans with respect to the deductible of such a  plan  after
 the  enrollee  has satisfied the [minimum] PLAN deductible [under 26 USC
 223], except for with respect to items or services that  are  preventive
 care  pursuant to 26 USC 223(c)(2)(C), in which case the requirements of
 this paragraph shall apply regardless  of  whether  the  [minimum]  PLAN
 deductible  [under  26 USC 223] has been satisfied. This subsection only
 applies to a prescription drug that is  either  (A)  a  brand-name  drug
 without  an  AB  rated  generic  equivalent, as determined by the United
 States Food and Drug Administration; or (B) a brand-name drug with an AB
 rated generic equivalent, as determined by the United  States  Food  and
 Drug  Administration,  and the insured has access to the brand-name drug
 through prior authorization by the  insurer  or  through  the  insurer's
 appeal  process,  including  any  step-therapy process; or (C) a generic
 drug the insurer will cover, with or without prior authorization  or  an
 appeal process.
 S. 8772                             5
 
   §  10.  Section 4 of a chapter of the laws of 2025 amending the insur-
 ance law relating to high deductible health  plans  and  health  savings
 accounts,  as  proposed  in  legislative  bills numbers S. 6895-A and A.
 5367-A, is amended to read as follows:
   §  4.  This  act  shall  take effect [immediately] JANUARY 1, 2027 AND
 APPLY TO ALL POLICIES AND CONTRACTS ISSUED, RENEWED, MODIFIED,  ALTERED,
 OR AMENDED ON OR AFTER SUCH DATE.
   §  11.  This  act  shall  take  effect immediately; provided, however,
 sections one, two, three, four, five, six, seven,  eight,  and  nine  of
 this  act shall take effect on the same date and in the same manner as a
 chapter of the laws of 2025 amending the insurance law relating to  high
 deductible  health  plans  and  health  savings accounts, as proposed in
 legislative bills numbers S. 6895-A and A. 5367-A, takes effect.
Every fact on this page links to its source, starting with the official bill record.